← Back to Clinical Trials
Recruiting NCT05546307

NCT05546307 Interest of Prior Relaxation on the Recordings of the SomatoSensory Evoked Potentials

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05546307
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire, Amiens
Condition Relaxation
Study Type INTERVENTIONAL
Enrollment 242 participants
Start Date 2022-09-15
Primary Completion 2025-07

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
SSEPrelaxation session

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 242 participants in total. It began in 2022-09-15 with a primary completion date of 2025-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Many factors influence the quality and duration of SomatoSensory Evoked potentials (SSEP). Some are related to the technique : type of electrodes, intensity of stimulation, stimulation site ; others are related to the patient : poor state of relaxation of the patient generating muscle artefacts; hypersensitivity of the patient to electrical stimuli making the examination unpleasant; examination time considered too long. However, the patient's relaxed state is essential to the quality of the signal . Thus the duration of an examination is very variable : between 30 and 75 minutes for the upper limbs.... For several months, the investigators provide relaxation to some patients just before the examination. Results seem to be positive. The investigators aim to study the effect of relaxation session on the quality of the SSEP recordings. Fifteen-minutes relaxation session will be provided by a nurse trained to the relaxation. The investigators will compare two groups : one group with one relaxation session before the examination and one group without relaxation session before the examination. The investigators chose to study the influence of relaxation session on (i) the artifacts rejection rate by the machine for the recordings of SSEP by stimulation of the median nerve to the upper limbs (ii) the duration of the examination (iii) the patient experience

Eligibility Criteria

Inclusion Criteria: * Any patient addressed for a study of the somatosensory evoked potentials in upper limbs * Patients between 18 to 70 years old. * Patients able to understand the instructions of the relaxation session and the examination. * Patient providing informed consent exclusion criteria Exclusion Criteria: * No availability of a technician trained in relaxation * Patient's refusal to participate in the protocol

Contact & Investigator

Central Contact

Caroline CARRE

✉ carre.caroline@chu-amiens.fr

📞 03 22 08 77 76

Frequently Asked Questions

Who can join the NCT05546307 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Relaxation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05546307 currently recruiting?

Yes, NCT05546307 is actively recruiting participants. Contact the research team at carre.caroline@chu-amiens.fr for enrollment information.

Where is the NCT05546307 trial being conducted?

This trial is being conducted at Amiens, France.

Who is sponsoring the NCT05546307 clinical trial?

NCT05546307 is sponsored by Centre Hospitalier Universitaire, Amiens. The trial plans to enroll 242 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology